We start by asking ‘what is the business challenge that communications can solve?’ Then, for every client, brand and brief, we combine strategy, science and a dose of creativity with a deeply human culture to create Unexpected Work that works.
- Agency description
We are DDB Remedy, a global creative agency dedicated to health and wellness.
We do everything – from grand global strategies to bespoke experiences and content, from South Korea to Brazil, from medical aesthetics to rare diseases and everything in-between.
As part of the DDB global advertising network, we share the home of creativity with adam&eveDDB, the world’s leading agency, and we have the support of OMNICOM, a global leader in modern marketing solutions.
As with all our sister DDB agencies in the world, we believe the best idea is the one that resonates at an emotional level but connects in an unexpected way. The only path to genuinely unexpected works is through creativity that is individual, surprising and interesting enough to raise an eyebrow, cause jaws to drop and sales to soar. It’s having the fresh perspective and raw energy to bring something into the world that no one’s ever seen before. It’s about having the courage to shake things up and maybe even tear a few things down.
For every client partner, every brand, every brief, we find the ownable emotion, the one that makes people act and we combine it with our additional driving factor – the unexpected – to create unexpected work that works. For us, the best idea is the one you never saw coming; it catches you so off guard and you can’t look away.
Unexpected works also means that diversity in a broader sense is an imperative for us. You can’t create the unexpected if you only work with the usual suspects. We are diverse in personality, gender, sexual orientation, nationality, background, age, and class – to name just a few. Bringing together diverse thinkers with diverse backgrounds means that we promote a culture that is wildly creative and as human as the work that we do.
We are proud to be who we are and do what we do. We are proud of Unexpected Works. Come and find out more.
- Contact details
- 12 Bishop's Bridge road W2 6AA London
- Key contact
- Hazel Soanes
- Chief Executive Officer
- 07725 965038
- 2022 Agency Data
2021 awardsTotal staff100-149 staffBillings from UK creative healthcare workHealthcare staff100-149 staffTotal agency billingsAgency ageBetween 15 and 20 yearsSocial media footprintStatusNETWORKEDApproximate percentage of advertising, branding, creative or design work in the UK healthcare market10-19%
- This information was supplied or confirmed by DDB Remedy. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- 2021 PM Society Awards:
Finalist, Internal communications, Effectiveness,
FREEDOM TO BE DE&I campaign
2021 PM Society Awards:
Finalist, DE&I in creative communications,
FREEDOM TO BE DE&I campaign
- This may contain additional awards supplied by DDB Remedy that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
COVID-19 Updates and Daily News
- Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
- Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca’s mild combination asthma reliever approved in UK
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....